Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysis
- 1 June 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (2) , 335-341
- https://doi.org/10.1016/s0360-3016(01)01442-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysisInternational Journal of Radiation Oncology*Biology*Physics, 2000
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Timing of Computed Tomography–Based Postimplant Assessment Following Permanent Transperineal Prostate BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE CANCER?Urologic Clinics of North America, 1996
- Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinomaCancer, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995
- Standards for breast-conservation treatmentCA: A Cancer Journal for Clinicians, 1992